These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
224 related articles for article (PubMed ID: 9511035)
1. In-vitro bactericidal efficacy of sub-MIC concentrations of liposome-encapsulated antibiotic against gram-negative and gram-positive bacteria. Beaulac C; Sachetelli S; Lagace J J Antimicrob Chemother; 1998 Jan; 41(1):35-41. PubMed ID: 9511035 [TBL] [Abstract][Full Text] [Related]
2. Fusion between fluid liposomes and intact bacteria: study of driving parameters and in vitro bactericidal efficacy. Wang Z; Ma Y; Khalil H; Wang R; Lu T; Zhao W; Zhang Y; Chen J; Chen T Int J Nanomedicine; 2016; 11():4025-36. PubMed ID: 27574430 [TBL] [Abstract][Full Text] [Related]
3. Eradication of mucoid Pseudomonas aeruginosa with fluid liposome-encapsulated tobramycin in an animal model of chronic pulmonary infection. Beaulac C; Clément-Major S; Hawari J; Lagacé J Antimicrob Agents Chemother; 1996 Mar; 40(3):665-9. PubMed ID: 8851590 [TBL] [Abstract][Full Text] [Related]
5. Antibiotic treatment of multidrug-resistant organisms in cystic fibrosis. Conway SP; Brownlee KG; Denton M; Peckham DG Am J Respir Med; 2003; 2(4):321-32. PubMed ID: 14719998 [TBL] [Abstract][Full Text] [Related]
6. In vitro activity of S-(3,4-dichlorobenzyl)isothiourea hydrochloride and novel structurally related compounds against multidrug-resistant bacteria, including Pseudomonas aeruginosa and Burkholderia cepacia complex. Nicholson A; Perry JD; James AL; Stanforth SP; Carnell S; Wilkinson K; Anjam Khan CM; De Soyza A; Gould FK Int J Antimicrob Agents; 2012 Jan; 39(1):27-32. PubMed ID: 21993484 [TBL] [Abstract][Full Text] [Related]
8. Antimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strains. Alipour M; Halwani M; Omri A; Suntres ZE Int J Pharm; 2008 May; 355(1-2):293-8. PubMed ID: 18164881 [TBL] [Abstract][Full Text] [Related]
9. Preparation, properties and the effects of free and liposomal tobramycin on siderophore production by Pseudomonas aeruginosa. Poyner EA; Alpar HO; Brown MR J Antimicrob Chemother; 1994 Jul; 34(1):43-52. PubMed ID: 7961214 [TBL] [Abstract][Full Text] [Related]
10. Liposomal bismuth-ethanedithiol formulation enhances antimicrobial activity of tobramycin. Halwani M; Blomme S; Suntres ZE; Alipour M; Azghani AO; Kumar A; Omri A Int J Pharm; 2008 Jun; 358(1-2):278-84. PubMed ID: 18448284 [TBL] [Abstract][Full Text] [Related]
11. Enhanced bactericidal potency of nanoliposomes by modification of the fusion activity between liposomes and bacterium. Ma Y; Wang Z; Zhao W; Lu T; Wang R; Mei Q; Chen T Int J Nanomedicine; 2013; 8():2351-60. PubMed ID: 23847417 [TBL] [Abstract][Full Text] [Related]
12. Liposome-encapsulated antibiotics: preparation, drug release and antimicrobial activity against Pseudomonas aeruginosa. Lagacé J; Dubreuil M; Montplaisir S J Microencapsul; 1991; 8(1):53-61. PubMed ID: 1908898 [TBL] [Abstract][Full Text] [Related]
13. Comparison of the bactericidal action of amikacin, netilmicin and tobramycin in free and liposomal formulation against Pseudomonas aeruginosa. Omri A; Ravaoarinoro M Chemotherapy; 1996; 42(3):170-6. PubMed ID: 8983883 [TBL] [Abstract][Full Text] [Related]
14. Comparison of two culture methods for detection of tobramycin-resistant gram-negative organisms in the sputum of patients with cystic fibrosis. Van Dalfsen JM; Stapp JR; Phelps C; Stewart P; Burns JL J Clin Microbiol; 2002 Jan; 40(1):26-30. PubMed ID: 11773088 [TBL] [Abstract][Full Text] [Related]
15. In-vitro profile of a new beta-lactam, ceftobiprole, with activity against methicillin-resistant Staphylococcus aureus. Jones ME Clin Microbiol Infect; 2007 Jun; 13 Suppl 2():17-24. PubMed ID: 17488372 [TBL] [Abstract][Full Text] [Related]
17. [Antibacterial activity of sulopenem, a new parenteral penem antibiotic]. Inoue E; Komoto E; Taniyama Y; Mitsuhashi S Jpn J Antibiot; 1996 Apr; 49(4):338-51. PubMed ID: 8786625 [TBL] [Abstract][Full Text] [Related]
18. Bactericidal activity of ertapenem against major intra-abdominal pathogens. Borbone S; Cascone C; Santagati M; Mezzatesta ML; Stefani S Int J Antimicrob Agents; 2006 Nov; 28(5):396-401. PubMed ID: 17045463 [TBL] [Abstract][Full Text] [Related]
19. In vitro activity of para-guanidinoethylcalix[4]arene against susceptible and antibiotic-resistant Gram-negative and Gram-positive bacteria. Grare M; Mourer M; Fontanay S; Regnouf-de-Vains JB; Finance C; Duval RE J Antimicrob Chemother; 2007 Sep; 60(3):575-81. PubMed ID: 17626025 [TBL] [Abstract][Full Text] [Related]
20. Pharmacodynamics of intermittent- and continuous-infusion cefepime alone and in combination with once-daily tobramycin against Pseudomonas aeruginosa in an in vitro infection model. Tessier PR; Nicolau DP; Onyeji CO; Nightingale CH Chemotherapy; 1999; 45(4):284-95. PubMed ID: 10394012 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]